Royal Bank of Canada’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $7.1M | Sell |
|
|||||
|
2025
Q2 | $4.96M | Buy |
|
|||||
|
2025
Q1 | $897K | Sell |
|
|||||
|
2024
Q4 | $1.5M | Sell |
|
|||||
|
2024
Q3 | $1.79M | Buy |
|
|||||
|
2024
Q2 | $1.42M | Buy |
|
|||||
|
2024
Q1 | $1.17M | Buy |
|
|||||
|
2023
Q4 | $749K | Buy |
|
|||||
|
2023
Q3 | $321K | Buy |
|
|||||
|
2023
Q2 | $100K | Buy |
|
|||||
|
2023
Q1 | $54K | Sell |
|
|||||
|
2022
Q4 | $126K | Buy |
|
|||||
|
2022
Q3 | $20K | Buy |
|
|||||
|
2022
Q2 | $13K | Sell |
|
|||||
|
2022
Q1 | $68K | Sell |
|
|||||
|
2021
Q4 | $279K | Buy |
|
|||||
|
2021
Q3 | $69K | Buy |
|
|||||
|
2021
Q2 | $55K | Buy |
|
|||||
|
2021
Q1 | $27K | Buy |
|
|||||
|
2020
Q4 | $8K | Buy |
|
|||||
|
2020
Q3 | $1K | Sell |
|
|||||
|
2020
Q2 | $12K | Buy |
|
|||||
|
2020
Q1 | $4K | Sell |
|
|||||
|
2019
Q4 | $12K | Buy |
|
|||||
|
2019
Q3 | $6K | Hold |
|
|||||
|
2019
Q2 | $10K | Hold |
|
|||||
|
2019
Q1 | $9K | Buy |
|
|||||
|
2018
Q4 | $1K | Sell |
|
|||||
|
2018
Q3 | $9K | Buy |
|